A wireless power transmitting device for a wireless power communication system. A pharmaceutical composition for the prevention andor treatment of Kaposi’s sarcoma and HIV which comprises an therapeutically effective amount of at least one compound of the present invention in association with a pharmaceutically acceptable carrier. A performance monitoring display is generated including a topology map and a graphical representation of the performance parameter, which is positioned in the display relative to the components for which the parameter applies. The IDC connector has a number of terminals which correspond in position with the signal and power wires and a pair of grounding plates formed with bifurcated projections corresponding in position with the grounding wires and selected signal wires which require grounding signals. The wireless communication device may execute the response process in a second period before the first operation is performed. The compositions are useful in post-CMP cleaning processes.